trial · primary record
Ex vivo HEB-001-expanded donor-derived CD34+ hematopoietic stem cells
Poor Graft Function
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 3 |
| Primary completion | 2029-12-30 |
| Primary endpoint | Participants With Treatment-Related Acute Adverse Events |
| Registry ID | NCT07907172 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:11.855Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07907172
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.